Evaluation of the Anti-Tumor Activity of the Humanized Monoclonal Antibody NEO-201 in Preclinical Models of Ovarian Cancer

Overview of attention for article published in Frontiers in oncology, June 2020

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (71st percentile)
High Attention Score compared to outputs of the same age and source (89th percentile)

Mentioned by

twitter: 6 X users

patent: 1 patent

Citations

dimensions_citation: 9 Dimensions

Readers on

mendeley: 39 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 6 X posts from 6 X users, with an upper bound of 3,341 followers.

RT @PrecisionBiolo1: Precision Biologics announces that the study conducted by our collaborators at @NCICCR_WMB, demonstrating the effectiv…

04 Sep 2020

Reply Repost Favourite

RT @PrecisionBiolo1: Precision Biologics announces that the study conducted by our collaborators at @NCICCR_WMB, demonstrating the effectiv…

04 Sep 2020

Reply Repost Favourite

Precision Biologics announces that the study conducted by our collaborators at @NCICCR_WMB, demonstrating the effectiveness of the monoclonal antibody NEO-201 in Ovarian Cancer models, was published in the journal Frontiers in Oncology @FrontOncology https

04 Sep 2020

Reply Repost Favourite

Evaluation of the Anti-Tumor Activity of the Humanized Monoclonal Antibody NEO-201 in Preclinical Models of Ovarian Cancer. https://t.co/yPvIUg4vxr

09 Jul 2020

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 2 additional X posts.